Diabetes and obesity

ENDO 2022

Sebastian Meyhöfer, MD

Management of hyperglycemia for hospitalized patients

ENDO 2022

Sebastian Meyhöfer, MD

ANGPTL3 - New kid on the block?

ENDO 2022

Sebastian Meyhöfer, MD

Glucagon / GLP-1 agonist to treat obesity - a...

Transgender

ENDO 2022

Achim Wüsthof, MD

Bone mineral density under GnRH agonists

DSD / AGS

ENDO 2022

Achim Wüsthof, MD

CRF1 receptor antagonist beneficial for adjustment of...

ENDO 2022

Achim Wüsthof, MD

Complete androgen insensitivity syndrome: MRI screening...

Parathyroid

ENDO 2022

Heide Siggelkow, MD

Update: Guideline on hyperparathyroidism 2022

ENDO 2022

Heide Siggelkow, MD

Update: Guideline on hypoparathyroidism 2022

Neuroendocrinology and pituitary

ENDO 2022

Ilonka Kreitschmann-Andermahr, MD

Central diabetes insipidus from a patient's perspective

ENDO 2022

Ilonka Kreitschmann-Andermahr, MD

Weight trajectory as a predictor of cushing’s disease

ENDO 2022

Ilonka Kreitschmann-Andermahr, MD

Addiction to wireless mobile device and obesity

Calcium and bone

ENDO 2022

Heide Siggelkow, MD

Iron and phosphate metabolism